相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Progenitor Cells and Clinical Outcomes in Patients With Heart Failure
Ayman Samman Tahhan et al.
CIRCULATION-HEART FAILURE (2017)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Circulating Endothelial Progenitor Cells as a Predictor of Response to Cardiac Resynchronization Therapy: The Missing Piece of the Puzzle?
Natalia Antonio et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2014)
Changes in Circulating Progenitor Cells Are Associated With Outcome in Heart Failure Patients: A Longitudinal Study
Ana C. Alba et al.
CANADIAN JOURNAL OF CARDIOLOGY (2013)
Cardiac resynchronization therapy in patients with chronic heart failure is associated with anti-inflammatory and anti-remodeling effects
Adina Elena Stanciu et al.
CLINICAL BIOCHEMISTRY (2013)
Many response criteria are poor predictors of outcomes after cardiac resynchronization therapy: validation using data from the randomized trial
Joanna Boidol et al.
EUROPACE (2013)
An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure
John G. Cleland et al.
EUROPEAN HEART JOURNAL (2013)
Effects of cardiac resynchronization therapy on long-term quality of life: An analysis from the CArdiac Resynchronisation-Heart Failure (CARE-HF) study
Joltn G. F. Cleland et al.
AMERICAN HEART JOURNAL (2009)
Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke
Kon Chu et al.
STROKE (2008)
Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure
Yoav Michowitz et al.
HEART (2007)
Circulating endothelial progenitor cells in congestive heart failure
Mutsuko Nonaka-Sarukawa et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM)
Hans D. Theiss et al.
EUROPEAN HEART JOURNAL (2007)
Antiinflammatory effects of cardiac resynchronization therapy in patients with chronic heart failure
GN Theodorakis et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2006)
Circulating endothelial progenitor cells and cardiovascular outcomes
N Werner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Predictors of lack of response to resynchronization therapy
E Díaz-Infante et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events -: Proof of concept for the clinical importance of endogenous vascular repair
C Schmidt-Lucke et al.
CIRCULATION (2005)
Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death
D Fischer et al.
EUROPEAN HEART JOURNAL (2005)
Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease
C Heeschen et al.
CIRCULATION (2004)
Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance
M Hristov et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2004)
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure
M Valgimigli et al.
CIRCULATION (2004)
Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure - The Rotterdam Study
GS Bleumink et al.
EUROPEAN HEART JOURNAL (2004)
Endothelial progenitor cells - Mobilization, differentiation, and homing
M Hristov et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Cardiac resynchronization in chronic heart failure
WT Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease
M Vasa et al.
CIRCULATION RESEARCH (2001)